Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 12,280
+350 (2.93%)
At close: Oct 2, 2025
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 735.05 billion as of October 6, 2025. Its market cap has increased by 126.43% in one year.
Market Cap
735.05B
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,280.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 735.05B, an increase of 1,694.56%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 735.05B | 47.95% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | 1,037.07B | 103.77% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |